Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...

Trying to keep your blood sugar in a healthy range? Diabetes experts share everyday habits that may be causing it to rise.

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with chronic migraines. Participants experienced nearly a 50% reduction in ...

With specific strategies, people with diabetes can enjoy the buffet and keep blood sugar stable. If picking one thing off the ...

A Milwaukee woman shares her experience of becoming a mother at 42, highlighting the increasing number of women over 40 ...

Negotiations are ongoing in New York to agree the latest UN political declaration on non-communicable diseases (NCDs) and ...

We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

The “Food is Medicine” movement depends on federal funding threatened by the reconciliation bill, the Federation of Virginia ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Alumni Nicole Friedland (Merrill ’89, community studies) and Brett King (Crown ’92, chemistry) both spoke at the National ...

Type 2 diabetes is more aggressive in young people, harder to manage and more likely to lead to a premature death.

A study presented at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) reveals ...